Research and Markets: The Japanese Interventional Cardiology Devices Market, Driven By Coronary Stents Is Forecast To Reach $1.4 Billion In 2015.Interventional Cardiology interventional cardiology Cardiology The subspecialty of cardiology dedicated to the diagnosis, medical and mechanical therapy, pre- and post-procedure management of adult patients with acute and chronic forms of cardiovascular disease amenable to catheter-based Devices: Coronary Stents to Drive Growth" to their offering.
"Japan Interventional Cardiology Devices Market: Coronary Stents to Drive Growth" report is an essential source of data and analysis on the Japanese interventional cardiology market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on five market categories, namely, coronary stent, PTCA PTCA
percutaneous transluminal coronary angioplasty
PTCA Percutaneous transluminal coronary angioplasty, see there balloon, cardiac catheter cardiac catheter
A long, fine catheter that can be passed into the chambers of the heart via a vein or artery as a means of withdrawing samples of blood, measuring pressures within the heart's chambers or great vessels, or injecting contrast media. , coronary guidewire, and arteriotomy closure devices. The report identifies the key trends shaping and driving the dynamism in the Japanese interventional cardiology market. It also provides insight into the prevalent competitive landscape and on the emerging players who are expected to bring significant shifts in the market standing of the existing leaders. In addition, the report analyses the M&A landscape with special focus on the market participants that have been the most M&A active. The report also provides valuable insight on the pipeline products within the Japanese interventional cardiology market.
The Japanese interventional cardiology devices market is forecast to grow by 6% annually during 2008-2015 to reach $1.4 billion by 2015. The market is expected to be driven by increasing incidence of coronary diseases, increasing preference for minimally invasive procedures Minimally invasive surgical procedures avoid open invasive surgery in favor of closed or local surgery with less trauma. These procedures involve use of laparoscopic devices and remote-control manipulation of instruments with indirect observation of the surgical field through an , and product innovation enabling physicians to perform Percutaneous Coronary Intervention Percutaneous coronary intervention (PCI), commonly known as coronary angioplasty or simply angioplasty, is a therapeutic procedure to treat the stenotic (narrowed) coronary arteries of the heart found in coronary heart disease. (PCI (1) (Payment Card Industry) See PCI DSS.
(2) (Peripheral Component Interconnect) The most widely used I/O bus (peripheral bus). ) for complex cases.
The coronary stents market accounted for 74% of the total interventional cardiology devices market in Japan in 2008. It grew at a Compound Annual Growth Rate (CAGR CAGR
See: Compound Annual Growth Rate ) of 16% during 2001-2008, and was valued at $718m in 2008. The introduction of Drug Eluting Stents (DES) in 2004 by Cordis fuelled growth in the market. In 2008, the DES market accounted for more than 80% of the total coronary stents market. This phenomenal growth was supported by strong clinical evidence showing reduced restenosis rates with DES compared to Bare Metal 1. bare metal - New computer hardware, unadorned with such snares and delusions as an operating system, an HLL, or even assembler. Commonly used in the phrase "programming on the bare metal", which refers to the arduous work of bit bashing needed to create these basic tools Stents (BMS BMS
Bachelor of Marine Science ).
Increasing Incidence of Coronary Disease and Low Preference for Invasive Procedures to Drive Demand for Interventional Cardiology Devices
Heart disease has emerged as the second major cause of death in Japan in the last few decades, and Coronary Heart Disease coronary heart disease: see coronary artery disease.
coronary heart disease
or ischemic heart disease
Progressive reduction of blood supply to the heart muscle due to narrowing or blocking of a coronary artery (see atherosclerosis). (CHD CHD coronary heart disease.
Latin Chirurgiae Doctor (Doctor of Surgery)
n.pr See disease, coronary heart.
canine hip dysplasia. ) accounts for approximately half of the heart disease-related deaths in the country. The rise in incidence rate has been largely attributed to socioeconomic development Socio-economic development is the process of social and economic development in a society. Socio-economic development is measured with indicators, such as GDP, life expectancy, literacy and levels of employment. and a growing westernization west·ern·ize
tr.v. west·ern·ized, west·ern·iz·ing, west·ern·iz·es
To convert to the customs of Western civilization.
west of lifestyles, including greater availability of high-calorie and high-fat foods, as well as widespread sedentary sedentary /sed·en·tary/ (sed´en-tar?e)
1. sitting habitually; of inactive habits.
2. pertaining to a sitting posture.
of inactive habits; pertaining to a fat, castrated or confined animal. work patterns coupled with high mental stress. This is one of the factors which has led to a surge in demand for percutaneous percutaneous /per·cu·ta·ne·ous/ (per?ku-ta´ne-us) performed through the skin.
Passed, done, or effected through the unbroken skin. procedures. Since the general prognosis of Coronary Artery Disease coronary artery disease, condition that results when the coronary arteries are narrowed or occluded, most commonly by atherosclerotic deposits of fibrous and fatty tissue. (CAD) patients in Japan is much better as compared to that in the west, physicians routinely go for PCI as against surgery.
The Interventional Cardiology Devices Market in Japan Continues to be Dominated by Multinational Players
The Japanese market for interventional cardiology devices is dominated by US players. Terumo Corporation, Boston Scientific The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, , Cordis, Medtronic and Abbott Laboratories Abbott Laboratories (NYSE: ABT) is a diversified pharmaceuticals and health care company. It has over 65,000 employees and operates in 130 countries. The corporate headquarters are in Abbott Park, Illinois, a neighborhood of North Chicago, Illinois. remain the leading competitors in the Japanese interventional cardiology market. Together, these companies accounted for 90% of the market share in 2008. Local player Terumo is the market leader with 29% market share. Boston Scientific and Cordis dominate the coronary stents market with a combined market share of 42%.
"Japan Interventional Cardiology Devices Market: Coronary Stents to Drive Growth" report is an essential source of data and analysis on the Japan interventional cardiology market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on five market categories, namely, cardiac catheter, coronary guidewire, coronary stent, PTCA balloon and arteriotomy closure devices. The report identifies the key trends shaping and driving the dynamism in the Japanese interventional cardiology market. It also provides insight into the prevalent competitive landscape and on the emerging players who are expected to bring significant shift in the market standing of the existing leaders. In addition, the report analyses the M&A landscape with special focus on the market participants that have been the most M&A active. The report also provides valuable insight on the pipeline products within the Japanese interventional cardiology market.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by a team of industry experts.
The report estimates that the Japan interventional cardiology devices market was valued at around $972 m in 2008. The market is forecast to reach $1.4 billion by 2015 with a Compound Annual Growth Rate (CAGR) of 6%. The market is expected to be driven by increasing incidence of coronary disease, increasing preference for minimally invasive procedures, and product innovation enabling physicians to perform Percutaneous Coronary Intervention (PCI) for complex cases.
The report analyses market opportunities and challenges for the interventional cardiology devices companies in Japan. Its scope includes:
* Market size data and information on five interventional cardiology market categories, namely, cardiac catheter, coronary guidewire, coronary stent, PTCA balloon and arteriotomy closure devices
* Annualized annualized
Of or relating to a variable that has been mathematically converted to a yearly rate. Inflation and interest rates are generally annualized since it is on this basis that these two variables are ordinarily stated and compared. market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated company shares data for 2008
* Analysis and review of the key events and milestones that will impact the future of the Japan interventional cardiology market. Each trend independently researched to provide qualitative analysis Qualitative Analysis
Securities analysis that uses subjective judgment based on nonquantifiable information, such as management expertise, industry cycles, strength of research and development, and labor relations. of what the implications on sectors are, and how are companies responding to these trends
* Insightful review of key industry drivers, restraints and challenges which are likely to impact the Japan interventional cardiology market
* In-depth analysis of the M&A landscape with a strong emphasis on the market players, likely to remain active in the near future
* The report covers information on the leading market players such as Medtronic, Inc., Terumo Corporation, Cordis Corporation, Boston Scientific Corporation, and Abbott Laboratories. It also provides insights into the competitive landscape and the leading pipeline products and technologies
* Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
* Develop business strategies by understanding the trends shaping and driving the Japan interventional cardiology Market
* Design and develop your product development, marketing and sales strategies by identifying the market categories poised for a strong growth
* Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return
* Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape
* Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the Japan interventional cardiology market in future
* Effectively plan your M&A and partnership strategies by identifying companies with the most promising pipeline
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
* What's the next big thing in the Japan interventional cardiology technology landscape? - Identify, understand and capitalize
For more information visit http://www.researchandmarkets.com/research/1eb155/japan_intervention
|Printer friendly Cite/link Email Feedback|
|Article Type:||Industry overview|
|Date:||Nov 10, 2009|
|Previous Article:||Wyse Technology Partners With Citrix Systems on Desktop Virtualization Program.|
|Next Article:||ArQule, Inc. to Present at Lazard Capital Markets Sixth Annual Healthcare Conference on November 17, 2009.|